Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...
Good afternoon, and thank you for joining today's conference call to discuss Peraso Fourth Quarter and Full Year 2025 financial ...
AI is rapidly reshaping the landscape of surgical oncology. However, its true potential lies not in isolated tools, but rather ...
AI-enabled platform auto-categorizes HER2 cases during scanning, allowing pathologists to review pre-analyzed results ...
Attorneys propose framework for monitoring AI developers and protecting whistleblowers and consumers. AI will continue ...
The Melo Group, one of South Florida’s most active and long‑standing real estate developers, is proud to announce the topping off of Downtown 6 — achieved in record time, completing 60 stories and 824 ...
Good afternoon, and thank you for joining today's conference call. To discuss Peraso Inc.'s fourth quarter and full year 2025 financial results. The press release and Form 8-Ks are available on Peraso ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results